Neosync is an early stage company developing a new treatment for major depression based on Transcranial Magnetic Stimulation (TMS). The treatment–named NEST (Neosync EEG Synchronized TMS) and undergoing clinical trials–is based on the idea that depression patients tend to have overly rhythmic brain activity, [Read more…] about Neosync ranked #30 Holder of Pervasive Neurotech Intellectual Property*
Just a quick heads-up to the SharpBrains community: we are wrapping up a comprehensive market report on Pervasive Neurotechnologies (non-invasive, scalable, potentially ubiquitous). To learn when it becomes available, keep tuned via our e‑Newsletter.
See below, in alphabetical order, a few of the organizations to be profiled in the report, given their relevant intellectual property portfolios (primarily patents). [Read more…] about Upcoming market report on Pervasive Neurotechnology